Cefdinir
Product Images NDC 68071-2564

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-2564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2564 6)

Label for NuCare Pharmaceuticals Inc. cefdinir oral suspension, 250 mg per 5 mL concentration, in a 60 mL bottle. The label includes the NDC number 68071-2564-6, manufacturer information Alkem Laboratories Ltd., patient instructions, a prominent warning to keep out of reach of children, and storage instructions to keep at 68-77°F. The label also features barcodes, batch identifiers, and a reminder to consult the manufacturer's label for a full list of ingredients.*

FDA Label Image

Str-new (Str New)

Chemical structure of cefdinir showing the molecular arrangement including thiazole and beta-lactam rings, hydroxyl, amino, carboxyl groups, and other structural features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.